The Global Pressure Infusion Bags Market was valued at US$ 300.0 Million in 2021 and is expected to reach US$ 494.5 Million by 2029, finds Future Market Insights (FMI) in a recent market survey.
| Data Points | Market Insights |
|---|---|
| Market Value 2021 | USD 300.0 Million |
| Market Value 2022 | USD 318.6 Million |
| Market Value 2029 | USD 494.5 Million |
| CAGR 2022 to 2029 | 6.5% |
| Share of Top 5 Countries | 73.7% |
| Key Players | The key players in the pressure infusion bags market are Vyaire Medical Inc.; Spengler SAS; Merit Medical Systems, Inc.; Statcorp Medical; Armstrong Medical; Salter Labs; Sarstedt AG & Co. KG; Smiths Medical; SunMed; Tapmedic LLC; VBM Medizintechnik GmbH; Rudolf Riester GmbH; Friedrich Bosch GmbH & Co. KG; Accoson Ltd.; and ERKA. Kallmeyer Medizintechnik GmbH & Co. KG. |
The measurement of continuous beat-to-beat blood pressure by a pressure infuser coupled with other monitoring devices is an invasive method that is widely used by physicians.
Major fluids in rapid infusion include blood, blood products, blood expanders and intravenous solution. Certain factors that are driving the pressure infusion bags market growth include rapid infusion of blood and drugs that are necessary for patients suffering from trauma-induced haemorrhage, postpartum haemorrhage, and cardiac surgery.
An increase in the number of transfusion and emergency cases accounts for the rise in demand for pressure infusion bags.
Likewise, the rising prevalence of chronic diseases, surge in emergency transfusion cases, technological advancements and increasing Research and Development initiatives anticipates market growth. The growing cases of blood transfusion in emergencies, coupled with the growing geriatric & immunocompromised population account for the increase in demand for pressure infusion bags.
Globally, the burden of cancer incidence and mortality is rapidly growing among the growing population. The high prevalence reflects an increase in both ageing and growth of the population, as well as changes in the prevalence and distribution of the main risk factors for cancer, associated with socio-economic development.
According to the World Cancer data, in 2020 around 18.1 million cancer cases were estimated around the world. Among these, annually around 1.24 Million blood cancer cases occur worldwide. Blood cancers are characterized by the overproduction of an abnormal type of cell.
The pressure infusion bags market holds nearly 21.4% of the US$ 1.4 Billion Infusion Bags Market in 2021. Advancements and developments made in the pressure infusion bags market in recent years are expected to boost the growth of the market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 6.34% |
| H1, 2022 Projected | 6.48% |
| H1, 2022 Outlook | 6.38% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 4 ↑ |
According to Future Market Insights Analysis, the global pressure infusion bags market will observe an increased change in the Basis Point Share (BPS) by nearly 04 units in H1- 2022 (O) as compared with H1-2021. This was majorly due to the impact of the pressure infusion bags in the perioperative period for protection against air embolism, thus determining increased adoption.
This is based on value consumption as per the company's reported revenue. The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS.
Key driving factors in the market include the cost-effectiveness of pressure infusion bags within perioperative settings, and the aid provided by pressure infusion bags to anesthesiologists with tightly controlled flow rates for enhanced patient safety.
Conversely, low induction into under-developed regions will restrain the growth of the pressure infusion bags market. The development of intravenous smart pumps with built-in drug libraries for secondary medication administration proves beneficial to the providers while monitoring patient stability. This factor is set to further promote the positive impact of the BPS change observed within the market in H1-2022.
Currently, medical treatments are reliant on advanced technological development and innovative designs in the healthcare sector. An increasing number of medical emergencies and rising cases of chronic diseases have urged the need for advanced medical products that will benefit patients’ treatment effectively.
Pressure infusion bags are widely used in the medical sector for rapid IV infusion, to infuse blood, drugs, and, and invasive pressure monitoring. The demand for pressure infusion bags grew at a CAGR of 5.4% between 2014 and 2021.
One of the significant factors contributing to the growth of the global pressure infusion bags market is related to the increasing significance of invasive pressure monitoring and assessment of wounds in arterial conditions.
The application of pressure infusion bags has grown significantly in hospitals and outpatient centers for enhanced and instantaneous treatment. Moreover, increasing the focus of manufacturers towards the upsurge demand for cost-effective product lines has led to a focus on developing reliable products.
With such developments taking place, the growth in the global pressure infusion bags market is expected to grow significantly in the coming years. Considering this, FMI expects the global pressure infusion bags to grow at a CAGR of 6.5% through 2029.
Principal Consultant
The restraints for the global pressure infusion bags market include pressure on pricing, lack of specialized personnel, and lack of awareness of handling the blood products. As the pressure infusion bags space is a fairly fragmented market, and also due to the high volume & low-value nature of the markets, the prominent players are actively focusing on strengthening inorganic growth.
The competition among manufacturers from China is driving the price down owing to the availability of low-cost labor as compared to other countries manufacturing costs.
Even if many countries have programs for expansion and education for infusion therapy, lack of awareness and proper training the clinicians and nursing staff affect the use of pressure infusion bags. Pressure infusion bags which are mostly used to minimize the chances of cross-contamination during the fluid infusion process makes them effective tools to ensure patient safety.
An increase in awareness about patient safety is also a boon for the entire pressure infusion bags market. There have been many concerns raised against the high incidence of critical incidents which are related to the devices. A great number of these incidents have been reported to the Medical Devices Agency (which is now a part of the Medicines and Healthcare products Regulatory Agency (MHRA)) and most of these incidents are considered to be attributable to human error.
Additionally, a lack of skilled professionals and the occurrence of complications can be attributed to the misuse of the device, such as incorrect calibration or interpretation of the pressure display, etc. A high incidence of long-term complications associated with invasive arterial blood pressure monitoring has also been reported.
Thus, the reliability and reproducibility of this instrument are highly dependent on skilled technicians or operators who interpret the results of pressure monitoring devices.
The COVID-19 pandemic has caused unprecedented challenges for surgical staff to minimize exposure to coronavirus and save medical resources without harmful patient outcomes, following the statement of each surgical society. Despite strict lockdowns and restrictions, patients with critical diseases and cancers still had to receive surgery as usual; whereas, cases with benign diseases were postponed.
Thus, the outbreak disruption due to a halt in transportation, lack of supplies, and lack of labor projected a short-term downfall in medical equipment production. Although there was a postponement in the procedures, the pressure infusion bags market anticipated a significant short-term negative impact owing to the lack of supplies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2021, the USA accounted for about 96.4% of the North American pressure infusion bags market. The country is witness to accounting for a high revenue share and has been highly driven by raised awareness regarding such health conditions for early diagnosis and treatment. In addition, the rising prevalence of various chronic conditions is also fueling market growth across the country.
According to CDC, around 1,000,000 people are suffered from Traumatic Injuries per year. Traumatic Injury is the single largest cause of death from injury in the USA and is the leading cause of death for individuals up to the age of 45 years.
Germany is expected to account for 39.8% of the European Market by 2022. The country dominates the European market owing to the high prevalence of cancer among the population and the growing number of surgeries. For instance, in 2018, Germany spent $5,472 per capita on health, the second-highest amount in the EU.
Germany spends a greater proportion of its GDP on health (11.2%) than any other country in the EU. While 84.5% of health spending is publicly funded - again the highest share in the EU - out-of-pocket spending amounts to 12.5% and is below most other EU countries.
The market for pressure infusion bags in Japan is projected to grow at a 5.6% CAGR in the East Asian pressure infusion bags market throughout the forecast period. The rapid rise in Japan’s adult population suffering from cancer anticipates boosting the growth of the country’s pressure infusion bags market.
Age is an additional risk factor as the country has a highly aging population and an aging population is susceptible to chronic diseases like cancer. The main cause for the high incidence in Japan is imprecise, though smoking, obesity, and old age, are the strongest risk factors. The Japanese population is not at higher risk from obesity and smoking-related illnesses than the other markets.
Demand for pressure infusion bags in India is expected to rise at an impressive 9.9% CAGR over the forecast period. 90% of global trauma mortality occurs in low-and-middle-income countries. With the growing research activities and awareness for early treatment, there are greater chances that expect to offer lucrative opportunities for manufacturers in India.
Based on the Product, the disposable pressure infusion bags segment held the maximum share of 65.4 % in 2021, expanding at 7.2% CAGR during the forecast period. Disposable pressure infusion bags are highly preferred over reusable bags owing to avoid cross-contamination.
In terms of material, nylon will continue to be a prominent material segment of the pressure infusion bags market as there is increasing usage of polyester and nylon materials due to their durability and tensile properties. Nylon accounted for the highest market share of 62.9% in 2021 and is expected to dominate throughout the forecast period.
In terms of capacity, the pressure infusion bags with 500 cc capacity has gained traction and is accounting for 55.6% of the global market share in 2021 owing to the high demand for these bags.
The blood & drug infusion segment accounted for the highest market share of 72.1% in the year 2021 owing to the growing trauma cases.
Trauma-induced haemorrhage expects to continue to be a prominent segment of the pressure infusion bags market in the application type accounting for the highest share of 47.9% in 2021. An increase in the number of transfusion and emergency cases accounts for the rise in demand for pressure infusion bags.
By end user, hospitals hold over 66% of the market in 2021 and this trend is expected to continue during the forecast period as well. The hospital segment gains traction owing to the availability of advanced treatment technology and other policies in the hospitals.
Companies in the pressure infusion bags market are pursuing new product innovation and launches, regulatory approvals, and company expansions as key strategies. The global pressure infusion bags market is exceptionally fragmented with the presence of several players.
The players are heavily investing in research to develop a novel product as an effective strategy to provide products to end consumers with an effective minimum price. The key players are highly focused on strengthening their product portfolio and expanding their sales footprint across the globe by entering into strategic agreements with the local distributors which are essential to enhance distribution efficiency.
This is majorly practiced by manufacturers to increase their market share. Thereby, focusing on the development of novel and cost-effective pressure infusion bags to eradicate unmet needs. Along with this, the players are establishing distribution agreements to increase geographic reach.
For instance:
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | USD Million for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, United Kingdom, Germany, France, Italy, Spain, BENELUX, Russia, Rest of Europe, India, Thailand, Indonesia, Malaysia, Rest of South Asia, Japan, South Korea, China, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa, and Rest of Middle East & Africa |
| Key Segments Covered | Product, Capacity, Material, Application, Indication, End User, and Region |
| Key Companies Profiled | Vyaire Medical Inc.; Spengler SAS; Merit Medical Systems, Inc.; Statcorp Medical; Armstrong Medical; Salter Labs; Sarstedt AG & Co. KG; Smiths Medical; SunMed; Tapmedic LLC; VBM Medizintechnik GmbH; Rudolf Riester GmbH; Friedrich Bosch GmbH & Co. KG; Accoson Ltd.; ERKA. Kallmeyer Medizintechnik GmbH & Co. KG. |
| Report Coverage | Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The global pressure infusion bags market is worth US$ 300.0 Million in 2021 and is set to expand 1.6X over the next seven years.
The pressure infusion bags market is expected to reach US$ 494.5 Million by the end of 2029, with sales revenue expected to grow at a 6.5% CAGR.
The global market for pressure infusion bags is projected to reflect high demand in the forecast period with a CAGR of 6.5% owing to the rising prevalence of cancer cases and other chronic diseases along with the growth in the number of surgeries.
North America currently holds the largest market share in the pressure infusion bags market globally. North America currently holds 42.8% of the global market share in the pressure infusion bags market with the USA being the leading contributor with a market value of over US$ 123.7 Million in 2021.
The pressure infusion bags market in India is likely to grow at a CAGR of 9.9% during the forecast period, with a market share of around 2.8% in 2022 of the global market for pressure infusion bags. The rise in research and development activities in India, and growing awareness among the population are responsible for the growth of the pressure infusion bags market in India.
Advent focuses on research and development of cost-effective products, focus on mergers and acquisitions among the players in order to strengthen the market positions and development and frequent growth in demand for invasive monitoring are the major key trends in the pressure infusion bags market.
Japan’s market in pressure infusion bags is offering lucrative growth opportunities and is expected to exhibit healthy growth of 5.6% CAGR during the forecast period.
The USA, Germany, the United Kingdom, France, and China are the top 5 countries that are driving the demand for pressure infusion bags.
Leading companies of pressure infusion bags are Merit Medical, Smith Medical, ERKA, Sarstedt, Startcorp medical, Rudolf Riester, ERKA & VBM.
1. Executive Summary | Pressure Infusion Bags Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Identifying Ideal Material Characteristics
4.2. Highlighting Use Cases for Disposable / Reusable Products
5. Global Market Volume (in Units) Analysis 2014 to 2021 and Forecast, 2022 to 2029
5.1. Historical Market Volume (Units) Analysis, 2014 to 2021
5.2. Current and Future Market Volume (Units) Projections, 2022 to 2029
6. Global Market - Pricing Analysis
6.1. Average Pricing Analysis By Product
6.2. Pricing Break-up
6.2.1. Manufacturer-Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Market (Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029
7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Industry Value Added
8.1.3. Healthcare Expenditure and Sector Outlook
8.2. Forecast Factors - Relevance & Impact
8.3. Value Chain Analysis
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Opportunity
9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume Analysis By Product, 2014 to 2021
9.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast By Product, 2022 to 2029
9.3.1. Reusable Pressure Infusion Bags
9.3.2. Disposable Pressure Infusion Bags
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Capacity
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Capacity, 2014 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Capacity, 2022 to 2029
10.3.1. 500cc
10.3.2. 1000cc
10.3.3. 3000cc
10.3.4. Above 3000cc
10.4. Market Attractiveness Analysis By Capacity
11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Material
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Material, 2014 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Material, 2022 to 2029
11.3.1. Nylon
11.3.2. Polyurethane
11.3.3. Latex
11.3.4. Others
11.4. Market Attractiveness Analysis By Material
12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2029
12.3.1. Blood and Drug Infusion
12.3.2. Invasive Pressure Monitoring Procedures
12.4. Market Attractiveness Analysis By Application
13. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Indication
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis By Indications, 2014 to 2021
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indications, 2022 to 2029
13.3.1. Trauma-Induced Haemorrhage
13.3.2. Obstetric Haemorrhage
13.3.3. Coagulopathy during cardiopulmonary bypass
13.4. Market Attractiveness Analysis By Indication
14. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2029
14.3.1. Hospitals
14.3.2. Outpatient Facilities
14.3.3. Clinics
14.3.4. Long-Term Care Centres
14.4. Market Attractiveness Analysis By End User
15. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021
15.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. East Asia
15.3.5. South Asia
15.3.6. Oceania
15.3.7. Middle East and Africa
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
16.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
16.4.1. By Country
16.4.1.1. USA
16.4.1.2. Canada
16.4.2. By Product
16.4.3. By Capacity
16.4.4. By Material
16.4.5. By Application
16.4.6. By Indication
16.4.7. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Capacity
16.5.4. By Material
16.5.5. By Application
16.5.6. By Indication
16.5.7. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
17.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
17.4.1. By Country
17.4.1.1. Brazil
17.4.1.2. Mexico
17.4.1.3. Rest of Latin America
17.4.2. By Product
17.4.3. By Capacity
17.4.4. By Material
17.4.5. By Application
17.4.6. By Indication
17.4.7. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Capacity
17.5.4. By Material
17.5.5. By Application
17.5.6. By Indication
17.5.7. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
18.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
18.4.1. By Country
18.4.1.1. Germany
18.4.1.2. Italy
18.4.1.3. France
18.4.1.4. United Kingdom
18.4.1.5. Spain
18.4.1.6. BENELUX
18.4.1.7. Nordic
18.4.1.8. Rest of Europe
18.4.2. By Product
18.4.3. By Capacity
18.4.4. By Material
18.4.5. By Application
18.4.6. By Indication
18.4.7. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product
18.5.3. By Capacity
18.5.4. By Material
18.5.5. By Application
18.5.6. By Indication
18.5.7. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
19.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
19.4.1. By Country
19.4.1.1. China
19.4.1.2. Japan
19.4.1.3. South Korea
19.4.2. By Product
19.4.3. By Capacity
19.4.4. By Material
19.4.5. By Application
19.4.6. By Indication
19.4.7. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By Capacity
19.5.4. By Material
19.5.5. By Application
19.5.6. By Indication
19.5.7. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
20.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
20.4.1. By Country
20.4.1.1. India
20.4.1.2. Thailand
20.4.1.3. Indonesia
20.4.1.4. Malaysia
20.4.1.5. Singapore
20.4.1.6. Rest of South Asia
20.4.2. By Product
20.4.3. By Capacity
20.4.4. By Material
20.4.5. By Application
20.4.6. By Indication
20.4.7. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By Capacity
20.5.4. By Material
20.5.5. By Application
20.5.6. By Indication
20.5.7. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
21.1. Introduction
21.2. Pricing Analysis
21.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
21.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
21.4.1. By Country
21.4.1.1. Australia
21.4.1.2. New Zealand
21.4.2. By Product
21.4.3. By Capacity
21.4.4. By Material
21.4.5. By Application
21.4.6. By Indication
21.4.7. By End User
21.5. Market Attractiveness Analysis
21.5.1. By Country
21.5.2. By Product
21.5.3. By Capacity
21.5.4. By Material
21.5.5. By Application
21.5.6. By Indication
21.5.7. By End User
21.6. Market Trends
21.7. Key Market Participants - Intensity Mapping
21.8. Drivers and Restraints - Impact Analysis
22. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
22.1. Introduction
22.2. Pricing Analysis
22.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
22.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
22.4.1. By Country
22.4.1.1. South Africa
22.4.1.2. GCC Countries
22.4.1.3. Turkey
22.4.1.4. Rest of Middle East and Africa
22.4.2. By Product
22.4.3. By Capacity
22.4.4. By Material
22.4.5. By Application
22.4.6. By Indication
22.4.7. By End User
22.5. Market Attractiveness Analysis
22.5.1. By Country
22.5.2. By Product
22.5.3. By Capacity
22.5.4. By Material
22.5.5. By Application
22.5.6. By Indication
22.5.7. By End User
22.6. Market Trends
22.7. Key Market Participants - Intensity Mapping
22.8. Drivers and Restraints - Impact Analysis
23. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
23.1. Introduction
23.1.1. Market Value Proportion Analysis, By Key Countries
23.1.2. Growth Comparison of Global Market v/s Emerging Countries
23.2. China Market Analysis
23.2.1. Introduction
23.2.2. PEST Analysis
23.2.3. Market Value Proportion Analysis by Market Taxonomy
23.2.4. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
23.2.4.1. By Product
23.2.4.2. By Capacity
23.2.4.3. By Material
23.2.4.4. By Application
23.2.4.5. By Indication
23.2.4.6. By End User
23.2.5. China Market - Competition Landscape
23.3. India Market Analysis
23.3.1. Introduction
23.3.2. PEST Analysis
23.3.3. Market Value Proportion Analysis by Market Taxonomy
23.3.4. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
23.3.4.1. By Product
23.3.4.2. By Capacity
23.3.4.3. By Material
23.3.4.4. By Application
23.3.4.5. By Indication
23.3.4.6. By End User
23.3.5. India Market - Competition Landscape
23.4. Indonesia Market Analysis
23.4.1. Introduction
23.4.2. PEST Analysis
23.4.3. Market Value Proportion Analysis by Market Taxonomy
23.4.4. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
23.4.4.1. By Product
23.4.4.2. By Capacity
23.4.4.3. By Material
23.4.4.4. By Application
23.4.4.5. By Indication
23.4.4.6. By End User
23.4.5. Indonesia Market - Competition Landscape
24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies
24.2. Market Share Analysis of Top Players
24.3. Market Presence Analysis
24.3.1. By Regional Footprint of Players
24.3.2. Product Footprint by Players
24.3.3. Channel Footprint by Players
25. Competition Analysis
25.1. Competition Dashboard
25.2. Competition Benchmarking
25.3. Competition Deep Dive
25.3.1. Vyaire Medical Inc
25.3.1.1. Overview
25.3.1.2. Portfolio
25.3.1.3. Profitability by Market Segments (Solution/Region)
25.3.1.4. Regional Footprint
25.3.1.5. Strategy Overview
25.3.1.5.1. Marketing Strategy
25.3.1.5.2. Product Strategy
25.3.2. Spengler SAS
25.3.2.1. Overview
25.3.2.2. Portfolio
25.3.2.3. Profitability by Market Segments (Solution/Region)
25.3.2.4. Regional Footprint
25.3.2.5. Strategy Overview
25.3.2.5.1. Marketing Strategy
25.3.2.5.2. Product Strategy
25.3.3. Merit Medical Systems, Inc.
25.3.3.1. Overview
25.3.3.2. Portfolio
25.3.3.3. Profitability by Market Segments (Solution/Region)
25.3.3.4. Regional Footprint
25.3.3.5. Strategy Overview
25.3.3.5.1. Marketing Strategy
25.3.3.5.2. Product Strategy
25.3.4. Statcorp Medical
25.3.4.1. Overview
25.3.4.2. Portfolio
25.3.4.3. Profitability by Market Segments (Solution/Region)
25.3.4.4. Regional Footprint
25.3.4.5. Strategy Overview
25.3.4.5.1. Marketing Strategy
25.3.4.5.2. Product Strategy
25.3.5. Armstrong Medical
25.3.5.1. Overview
25.3.5.2. Portfolio
25.3.5.3. Profitability by Market Segments (Solution/Region)
25.3.5.4. Regional Footprint
25.3.5.5. Strategy Overview
25.3.5.5.1. Marketing Strategy
25.3.5.5.2. Product Strategy
25.3.6. Salter Labs
25.3.6.1. Overview
25.3.6.2. Portfolio
25.3.6.3. Profitability by Market Segments (Solution/Region)
25.3.6.4. Regional Footprint
25.3.6.5. Strategy Overview
25.3.6.5.1. Marketing Strategy
25.3.6.5.2. Product Strategy
25.3.7. Sarstedt AG & Co. KG
25.3.7.1. Overview
25.3.7.2. Portfolio
25.3.7.3. Profitability by Market Segments (Solution/Region)
25.3.7.4. Regional Footprint
25.3.7.5. Strategy Overview
25.3.7.5.1. Marketing Strategy
25.3.7.5.2. Product Strategy
25.3.8. Smiths Medical
25.3.8.1. Overview
25.3.8.2. Portfolio
25.3.8.3. Profitability by Market Segments (Solution/Region)
25.3.8.4. Regional Footprint
25.3.8.5. Strategy Overview
25.3.8.5.1. Marketing Strategy
25.3.8.5.2. Product Strategy
25.3.9. SunMed
25.3.9.1. Overview
25.3.9.2. Portfolio
25.3.9.3. Profitability by Market Segments (Solution/Region)
25.3.9.4. Regional Footprint
25.3.9.5. Strategy Overview
25.3.9.5.1. Marketing Strategy
25.3.9.5.2. Product Strategy
25.3.10. Tapmedic LLC
25.3.10.1. Overview
25.3.10.2. Portfolio
25.3.10.3. Profitability by Market Segments (Solution/Region)
25.3.10.4. Regional Footprint
25.3.10.5. Strategy Overview
25.3.10.5.1. Marketing Strategy
25.3.10.5.2. Product Strategy
25.3.11. VBM Medizintechnik GmbH
25.3.11.1. Overview
25.3.11.2. Portfolio
25.3.11.3. Profitability by Market Segments (Solution/Region)
25.3.11.4. Regional Footprint
25.3.11.5. Strategy Overview
25.3.11.5.1. Marketing Strategy
25.3.11.5.2. Product Strategy
25.3.12. Rudolf Riester GmbH
25.3.12.1. Overview
25.3.12.2. Portfolio
25.3.12.3. Profitability by Market Segments (Solution/Region)
25.3.12.4. Regional Footprint
25.3.12.5. Strategy Overview
25.3.12.5.1. Marketing Strategy
25.3.12.5.2. Product Strategy
25.3.13. Friedrich Bosch GmbH & Co. KG
25.3.13.1. Overview
25.3.13.2. Portfolio
25.3.13.3. Profitability by Market Segments (Solution/Region)
25.3.13.4. Regional Footprint
25.3.13.5. Strategy Overview
25.3.13.5.1. Marketing Strategy
25.3.13.5.2. Product Strategy
25.3.14. Accoson Ltd
25.3.14.1. Overview
25.3.14.2. Portfolio
25.3.14.3. Profitability by Market Segments (Solution/Region)
25.3.14.4. Regional Footprint
25.3.14.5. Strategy Overview
25.3.14.5.1. Marketing Strategy
25.3.14.5.2. Product Strategy
25.3.15. ERKA. Kallmeyer Medizintechnik GmbH & Co. KG
25.3.15.1. Overview
25.3.15.2. Portfolio
25.3.15.3. Profitability by Market Segments (Solution/Region)
25.3.15.4. Regional Footprint
25.3.15.5. Strategy Overview
25.3.15.5.1. Marketing Strategy
25.3.15.5.2. Product Strategy
26. Assumptions and Acronyms Used
27. Research Methodology
Explore Healthcare Insights
View Reports
Pressure Infusion Bags Market
